Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.

Earnings

Q3 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-11-09
REV		(EXPECTED)2021-11-09

Q2 2021		Est.		Actual		Surprise
EPS		-0.360		-0.230		0.1300
REV		1.000M		0		-1.000M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
ACER	Acer Therapeutics	2.57	-0.01	-0.58%		36.8M

Acer Therapeutics Questions & Anwsers

Q: What sector and industry does Acer Therapeutics (ACER) operate in?

Acer Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.

How do I buy Acer Therapeutics (ACER) stock?

You can purchase shares of Acer Therapeutics (NASDAQ: ACER) through any online brokerage.

View our list of the best stock brokerages.

Who are Acer Therapeutics's (ACER) competitors?

Other companies in Acer Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX), Cumberland (NASDAQ:CPIX) and Verona Pharma (NASDAQ:VRNA).

What is the target price for Acer Therapeutics (ACER) stock?

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by Needham on June 25, 2019. The analyst firm set a price target for 0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Acer Therapeutics (ACER)?

The stock price for Acer Therapeutics (NASDAQ: ACER) is $2.57 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Acer Therapeutics (ACER) pay a dividend?

There are no upcoming dividends for Acer Therapeutics.

When is Acer Therapeutics (NASDAQ:ACER) reporting earnings?

Acer Therapeutics’s Q3 earnings are confirmed for after-market on November 9, 2021.

Is Acer Therapeutics (ACER) going to split?

There is no upcoming split for Acer Therapeutics.

What sector and industry does Acer Therapeutics (ACER) operate in?

Acer Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD